Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126544461 | 12654446 | 1 | I | 20160809 | 20160816 | 20160816 | EXP | GB-MHRA-EYC 00143337 | GB-FRI-1000086801 | FOREST | 41.00 | YR | F | Y | 58.96000 | KG | 20160816 | OT | DK | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126544461 | 12654446 | 1 | PS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Oral | UNKNOWN | U | 20822 | TABLET | ||||||||
| 126544461 | 12654446 | 2 | SS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Oral | 10 MG EVERY OTHER DAY | U | 20822 | 10 | MG | TABLET | QOD | |||||
| 126544461 | 12654446 | 3 | SS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Oral | 5 MG EVERY OTHER DAY | U | 0 | 5 | MG | TABLET | QOD | |||||
| 126544461 | 12654446 | 4 | SS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Oral | 20 MG DAILY | U | 0 | TABLET | ||||||||
| 126544461 | 12654446 | 5 | SS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Oral | 10 MG DAILY | U | 0 | TABLET | ||||||||
| 126544461 | 12654446 | 6 | SS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Oral | ALTERNATE DAYS 10 MG AND 5 MG | U | 21046 | ORAL SOLUTION | ||||||||
| 126544461 | 12654446 | 7 | SS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Oral | ALTERNATE DAYS 7.5 MG AND 5 MG | U | 21046 | ORAL SOLUTION | ||||||||
| 126544461 | 12654446 | 8 | C | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | 0 | |||||||||||
| 126544461 | 12654446 | 9 | C | SULPHASALAZINE | SULFASALAZINE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126544461 | 12654446 | 1 | Anxiety |
| 126544461 | 12654446 | 6 | Anxiety |
| 126544461 | 12654446 | 8 | Product used for unknown indication |
| 126544461 | 12654446 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126544461 | 12654446 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126544461 | 12654446 | Blood pressure decreased | |
| 126544461 | 12654446 | Heart rate abnormal | |
| 126544461 | 12654446 | Palpitations | |
| 126544461 | 12654446 | Syncope | |
| 126544461 | 12654446 | Ventricular tachycardia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126544461 | 12654446 | 8 | 1997 | 0 |